PMID: 15232327Jul 3, 2004Paper

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder

Journal of Clinical Psychopharmacology
Eduard VietaEsteve Brugue

Abstract

Olanzapine is an effective drug for the long-term treatment of bipolar disorder but is associated with burdensome weight gain. Topiramate is a novel anticonvulsant that may induce weight loss in some patients. This is the first study to address the long-term efficacy and impact on weight of the combination of olanzapine and topiramate in bipolar patients. Twenty-six Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition bipolar spectrum patients received olanzapine plus topiramate cotherapy for treatment of their manic (n = 14), hypomanic (n = 6), depressive (n = 2), and mixed (n = 1) symptoms for 1 year. Three rapid cycling patients were also enrolled despite being euthymic. Efficacy was assessed with the Young Mania Rating Scale, the Hamilton Depression Rating Scale, and the Modified Clinical Global Impressions for Bipolar Disorder. Weight, body mass index, and side effects were collected at every visit. Thirteen (50%) patients completed the 1-year follow-up. By intent-to-treat, patients significantly improved from baseline in Young Mania Rating Scale scores (P < 0.0001), Hamilton Depression Rating Scale (P < 0.05), and Modified Clinical Global Impressions for Bipolar Disorder subscales (mania P < 0.0001, depre...Continue Reading

References

Mar 21, 2001·Bipolar Disorders·K N ChengappaJ S Brar
Jun 2, 2001·Journal of Clinical Psychopharmacology·J R CalabreseM D Shelton
Oct 11, 2001·Journal of Clinical Psychopharmacology·E VietaM Tohen
Apr 3, 2002·The Journal of Clinical Psychiatry·Susan L McElroyRobert M Post
Jun 4, 2002·The American Journal of Psychiatry·Mauricio TohenGary A Tollefson
Aug 13, 2002·Journal of Clinical Psychopharmacology·Eduard VietaFrancisco Arrufat
Nov 26, 2002·The Journal of Clinical Psychiatry·Michael Van AmeringenJonathan Oakman
Dec 10, 2002·The Journal of Clinical Psychiatry·Emmanuelle LevyGuy Chouinard
Dec 31, 2002·The American Journal of Psychiatry·Andrea FagioliniEllen Frank
Jan 14, 2003·The Journal of Clinical Psychiatry·John M ZajeckaKenneth W Sommerville
Feb 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Laksami N YathamArun Ravindran
Aug 26, 2003·The Journal of Clinical Psychiatry·Eduard VietaJosé Sánchez-Moreno
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Nov 12, 2003·Archives of General Psychiatry·Mauricio TohenAlan Breier
Dec 10, 2003·Archives of General Psychiatry·Mauricio TohenAlan Breier
Apr 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Mauricio TohenJoseph R Calabrese

❮ Previous
Next ❯

Citations

Feb 19, 2011·European Archives of Psychiatry and Clinical Neuroscience·A Carlo AltamuraBernardo Dell'Osso
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Trino BaptistaMaritza Martinez
Jul 14, 2007·International Journal of Clinical Practice·A TschonerC F Ebenbichler
May 20, 2008·CNS Drugs·Trino BaptistaSerge Beaulieu
Oct 23, 2009·CNS Drugs·Marcia Kauer-Sant'AnnaEduard Vieta
Apr 29, 2015·Expert Review of Clinical Pharmacology·Mathias Zink, Christoph U Correll
Sep 12, 2015·Expert Opinion on Drug Safety·Eva Maria PichlerMoritz Muehlbacher
Jun 15, 2005·Bipolar Disorders·Lakshmi N YathamUNKNOWN Canadian Network for Mood and Anxiety Treatments
May 23, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·S Gentile
May 24, 2008·Acta Psychiatrica Scandinavica·C TorrentE Vieta
Mar 14, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Marco MulaFrancesco Monaco
Feb 12, 2017·Chonnam Medical Journal·Ather Muneer
Apr 17, 2008·Harvard Review of Psychiatry·Lauren ShinNancy Noyes
Mar 30, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Salvatore Gentile
Feb 4, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Frank M C Besag, David Berry
Sep 4, 2016·The Cochrane Database of Systematic Reviews·Katie PigottAllan H Young
Aug 27, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·Guy Goodwin, Eduard Vieta
Nov 6, 2004·CNS Spectrums·Prakash S MasandAshwin A Patkar
Jul 16, 2005·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.